趋化因子和共刺激分子在儿童肺炎支原体肺炎发病机制中的研究进展
Research Progress of Chemokine and Costimulatory Molecules in the Pathogenesis of Mycoplasma pneumoniae Pneumonia in Children
DOI: 10.12677/ACM.2022.126857, PDF,   
作者: 辛春玲：青海大学研究生院，青海 西宁；吴秀萍*：青海大学附属医院儿科，青海 西宁
关键词: 肺炎支原体肺炎；趋化因子；共刺激分子；发病机制；研究进展;Mycoplasma pneumoniae Pneumonia； Chemokines； Costimulatory Molecules； Pathogenesis； Research Progress
摘要: 近年来由于肺炎支原体肺炎在临床上发病率持续升高，且具有病情变化多、进展快、严重者可导致多个系统损害等特点，是临床诊治中需要面对的难题，因此对于早期识别及评估MPP严重程度尤为重要。越来越多的研究证明趋化因子、共刺激分子等炎症性因子在肺炎支原体肺炎中发挥重要作用。趋化因子参与多种急慢性肺部炎性疾病；共刺激分子参与机体免疫反应，进而造成自身免疫性损伤。本文将趋化因子和共刺激分子在儿童肺炎支原体肺炎发病机制中的研究进展作如下综述。
Abstract: In recent years, as the clinical incidence rate of Mycoplasma pneumoniae pneumonia continues to rise, and it has the characteristics of many changes, rapid progress, and serious cases can lead to multiple system damage, which is a difficult problem in clinical diagnosis and treatment, so it is particularly important to identify and evaluate the severity of MPP in the early stage. More and more studies have proved that inflammatory factors such as chemokines and costimulatory mole-cules play an important role in Mycoplasma pneumoniae pneumonia. Chemokines are involved in many acute and chronic pulmonary inflammatory diseases. Costimulatory molecules participate in the body’s immune response, and then cause autoimmune injury. This paper reviews the research progress of chemokines and costimulatory molecules in the pathogenesis of Mycoplasma pneu-moniae pneumonia in children as follows.
文章引用：辛春玲, 吴秀萍. 趋化因子和共刺激分子在儿童肺炎支原体肺炎发病机制中的研究进展[J]. 临床医学进展, 2022, 12(6): 5937-5945. https://doi.org/10.12677/ACM.2022.126857

参考文献

[1] Zhao, M.C., Wang, L., Qiu, F.Z., et al. (2019) Impact and Clinical Profiles of Mycoplasma pneumoniae Co-Detection in Childhood Community-Acquired Pneumonia. BMC Infectious Diseases, 19, Article No. 835. [Google Scholar] [CrossRef] [PubMed]
[2] 丁臻博, 段晶, 鲁萍, 黄永坤, 赵亚玲, 罗艳. 支原体DNA载量和耐药基因23SrRNA的2063和2064位点突变检测在儿童支原体肺炎诊疗的应用[J]. 昆明医科大学学报, 2020, 41(7): 89-93.
[3] 刘记, 岑俊杰, 吕志跃, 吴忠道. 趋化因子CCL8及其在疾病研究中的进展[J]. 热带医学杂志, 2015, 15(9): 1287-1291.
[4] Charo, I.F. and Ransohoff, R.M. (2006) The Many Roles of Chemokines and Chemokine Receptors in Inflammation. The New England Journal of Medicine, 354, 610-621. [Google Scholar] [CrossRef] 
[5] Hallstrand, T.S., Hackett, T.L., Altemeier, W.A., Matute-Bello, G., Hansbro, P.M. and Knight, D.A. (2014) Airway Epithelial Regulation of Pulmonary Immune Homeostasis and Inflam-mation. Clinical Immunology, 151, 1-15. [Google Scholar] [CrossRef] [PubMed]
[6] Saraya, T., Kurai, D., Nakagaki, K., et al. (2014) Novel Aspects on the Pathogenesis of Mycoplasma pneumoniae Pneumonia and Therapeutic Implications. Frontiers in Microbiology, 5, Article No. 410. [Google Scholar] [CrossRef] [PubMed]
[7] Lee, J.W., Chun, W., Lee, H.J., et al. (2021) The Role of Macro-phages in the Development of Acute and Chronic Inflammatory Lung Diseases. Cells, 10, Article No. 897. [Google Scholar] [CrossRef] [PubMed]
[8] Shapouri-Moghaddam, A., Mohammadian, S., Vazini, H., et al. (2018) Macrophage Plasticity, Polarization, and Function in Health and Disease. Journal of Cellular Physiology, 233, 6425-6440. [Google Scholar] [CrossRef] [PubMed]
[9] Atri, C., Guerfali, F.Z. and Laouini, D. (2018) Role of Human Macrophage Polarization in Inflammation during Infectious Diseases. International Journal of Molecular Sciences, 19, Article No. 1801. [Google Scholar] [CrossRef] [PubMed]
[10] Martinez, F.O., Helming, L. and Gordon, S. (2009) Alternative Activa-tion of Macrophages: An Immunologic Functional Perspective. Annual Review of Immunology, 27, 451-483. [Google Scholar] [CrossRef] [PubMed]
[11] Deshmane, S.L., Kremlev, S., Amini, S. and Sawaya, B.E. (2009) Monocyte Chemoattractant Protein-1 (MCP-1): An Overview. Journal of Interferon & Cytokine Research, 29, 313-326. [Google Scholar] [CrossRef] [PubMed]
[12] Singh, S., Anshita, D. and Ravichandiran, V. (2021) MCP-1: Function, Regulation, and Involvement in Disease. International Immunopharmacology, 101, Article ID: 107598. [Google Scholar] [CrossRef] [PubMed]
[13] 崔莹莹, 王琳, 王玲玲. 肺炎支原体肺炎患儿外周血CCL2、CCL4、CXCL8、CXCL9水平与心肌损伤的关系[J]. 解放军医药杂志, 2020, 32(3): 48-53.
[14] Wells, T.N., Power, C.A., Shaw, J.P. and Proudfoot, A.E. (2006) Chemokine Blockers—Therapeutics in the Making. Trends in Pharmacological Sciences, 27, 41-47. [Google Scholar] [CrossRef] [PubMed]
[15] Oliveira, S.H.P., Lira, S., Martinez-A, C., Wiekowski, M., Sullivan, L. and Lukacs, N.W. (2002) Increased Responsiveness of Murine Eosinophils to MIP-1Beta (CCL4) and TCA-3 (CCL1) Is Mediated by Their Specific Receptors, CCR5 and CCR8. Journal of Leu-kocyte Biology, 71, 1019-1025.
[16] Dias, P.M. and Banerjee, G. (2013) The Role of Th17/IL-17 on Eosinophilic In-flammation. Journal of Autoimmunity, 40, 9-20. [Google Scholar] [CrossRef] [PubMed]
[17] Cheung, P.F., Wong, C.K. and Lam, C.W. (2008) Molecular Mechanisms of Cytokine and Chemokine Release from Eosinophils Acti-vated by IL-17A, IL-17F, and IL-23: Implication for Th17 Lymphocytes-Mediated Allergic Inflammation. The Journal of Immunology, 180, 5625-5635. [Google Scholar] [CrossRef] [PubMed]
[18] Liu, H., Liu, Z., Chen, J., et al. (2013) Induction of CCL8/MCP-2 by Mycobacteria through the Activation of TLR2/PI3K/Akt Signaling Pathway. PLOS ONE, 8, e56815. [Google Scholar] [CrossRef] [PubMed]
[19] Severa, M., Islam, S.A., Waggoner, S.N., et al. (2014) The Transcriptional Repressor BLIMP1 Curbs Host Defenses by Suppressing Expression of the Chemokine CCL8. The Journal of Immunology, 192, 2291-2304. [Google Scholar] [CrossRef] [PubMed]
[20] Sun, X., Jones, H.P., Hodge, L.M. and Simecka, J.W. (2006) Cy-tokine and Chemokine Transcription Profile during Mycoplasma pulmonis Infection in Susceptible and Resistant Strains of Mice: Macrophage Inflammatory Protein 1Beta (CCL4) and Monocyte Chemoattractant Protein 2 (CCL8) and Accu-mulation of CCR5+ Th Cells. Infection and Immunity, 74, 5943-5954. [Google Scholar] [CrossRef] 
[21] 黄慧, 徐作军. CXC趋化因子在急性肺损伤中的作用[J]. 国外医学(呼吸系统分册), 2005, 25(7): 489-492.
[22] Chien, J.W., Chu, Y.T., Yang, S.N., et al. (2012) Long-Acting Beta 2 Agonists Suppress IP-10 Expres-sion in Human Bronchial Epithelial Cells. Journal of Investigative Medicine, 60, 1048-1053. [Google Scholar] [CrossRef] 
[23] Baggiolini, M., Dewald, B. and Moser, B. (1997) Human Chemokines: An Update. Annual Review of Immunology, 15, 675-705. [Google Scholar] [CrossRef] [PubMed]
[24] Hayney, M.S., Henriquez, K.M., Barnet, J.H., et al. (2017) Serum IFN-γ-Induced Protein 10 (IP-10) as a Biomarker for Severity of Acute Respiratory Infection in Healthy Adults. Journal of Clinical Virology, 90, 32-37. [Google Scholar] [CrossRef] [PubMed]
[25] Liu, M., Guo, S., Hibbert, J.M., et al. (2011) CXCL10/IP-10 in In-fectious Diseases Pathogenesis and Potential Therapeutic Implications. Cytokine & Growth Factor Reviews, 22, 121-130. [Google Scholar] [CrossRef] [PubMed]
[26] Li, M., Chen, Y., Li, H., et al. (2021) Serum CXCL10/IP-10 May Be a Potential Biomarker for Severe Mycoplasma pneumoniae Pneumonia in Children. BMC Infectious Diseases, 21, Article No. 909. [Google Scholar] [CrossRef] [PubMed]
[27] Ng, P.C., Li, K., Chui, K.M., et al. (2007) IP-10 Is an Early Diagnostic Marker for Identification of Late-Onset Bacterial Infection in Preterm Infants. Pediatric Research, 61, 93-98. [Google Scholar] [CrossRef] [PubMed]
[28] Thair, S.A., Walley, K.R., Nakada, T.A., et al. (2011) A Single Nucleotide Polymorphism in NF-κB Inducing Kinase Is Associated with Mortality in Septic Shock. The Jour-nal of Immunology, 186, 2321-2328. [Google Scholar] [CrossRef] [PubMed]
[29] Chen, H.L., Hung, C.H., Tseng, H.I., et al. (2011) Plasma IP-10 as a Predictor of Serious Bacterial Infection in Infants Less than 4 Months of Age. Journal of Tropical Pediatrics, 57, 145-151. [Google Scholar] [CrossRef] [PubMed]
[30] Yang, Y., Shen, C., Li, J., et al. (2020) Plasma IP-10 and MCP-3 Levels Are Highly Associated with Disease Severity and Predict the Progression of COVID-19. Journal of Al-lergy and Clinical Immunology, 146, 119-127.E4. [Google Scholar] [CrossRef] [PubMed]
[31] Chen, Y., Wang, J., Liu, C., et al. (2020) IP-10 and MCP-1 as Bi-omarkers Associated with Disease Severity of COVID-19. Molecular Medicine, 26, 97. [Google Scholar] [CrossRef] [PubMed]
[32] Blot, M., Jacquier, M., Aho Glele, L.S., et al. (2020) CXCL10 Could Drive Longer Duration of Mechanical Ventilation during COVID-19 ARDS. Critical Care, 24, 632. [Google Scholar] [CrossRef] [PubMed]
[33] Chapoval, A.I., Ni, J., Lau, J.S., et al. (2001) B7-H3: A Cost-imulatory Molecule for T Cell Activation and IFN-Gamma Production. Nature Immunology, 2, 269-274. [Google Scholar] [CrossRef] [PubMed]
[34] 李玉静, 董万利. B7家族成员的研究新进展[J]. 国际免疫学杂志, 2011, 34(3): 221-226.
[35] Dong, H., Zhu, G., Tamada, K. and Chen, L. (1999) B7-H1, a Third Member of the B7 Family, Co-Stimulates T-Cell Proliferation and Interleukin-10 Secretion. Nature Medicine, 5, 1365-1369. [Google Scholar] [CrossRef] [PubMed]
[36] Blank, C., Gajewski, T.F. and Mackensen, A. (2005) Interaction of PD-L1 on Tumor Cells with PD-1 on Tumor-Specific T Cells as a Mechanism of Immune Evasion: Implications for Tumor Immu-notherapy. Cancer Immunology, Immunotherapy, 54, 307-314. [Google Scholar] [CrossRef] [PubMed]
[37] Mazanet, M.M. and Hughes, C.C. (2002) B7-H1 Is Expressed by Human Endothelial Cells and Suppresses T Cell Cytokine Synthesis. The Journal of Immunology, 169, 3581-3588. [Google Scholar] [CrossRef] [PubMed]
[38] Goto, S., Konnai, S., Okagawa, T., et al. (2017) Increase of Cells Expressing PD-1 and PD-L1 and Enhancement of IFN-γ Production via PD-1/PD-L1 Blockade in Bovine Myco-plasmosis. Immunity, Inflammation and Disease, 5, 355-363. [Google Scholar] [CrossRef] [PubMed]
[39] Hartley, G.P., Chow, L., Ammons, D.T., Wheat, W.H. and Dow, S.W. (2018) Programmed Cell Death Ligand 1 (PD-L1) Signaling Regulates Macrophage Proliferation and Activation. Cancer Immunology Research, 6, 1260-1273. [Google Scholar] [CrossRef] 
[40] 杨鹏. 负性协同刺激分子B7-H1在人结直肠癌表达的调控机制[D]: [硕士学位论文]. 苏州: 苏州大学, 2012.
[41] Chemnitz, J.M., Parry, R.V., Nichols, K.E., June, C.H. and Riley, J.L. (2004) SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation. The Journal of Immunology, 173, 945-954. [Google Scholar] [CrossRef] [PubMed]
[42] Keir, M.E., Butte, M.J., Freeman, G.J. and Sharpe, A.H. (2008) PD-1 and Its Ligands in Tolerance and Immunity. Annual Review of Immunology, 26, 677-704. [Google Scholar] [CrossRef] [PubMed]
[43] Johnson, R., Wen, T. and Dong, H. (2020) Bi-directional Signals of PD-L1 in T Cells That Fraternize with Cancer Cells. Nature Immunology, 21, 365-366. [Google Scholar] [CrossRef] [PubMed]
[44] Vincent-Fabert, C., Roland, L., Zimber-Strobl, U., Feuillard, J. and Faumont, N. (2019) Pre-Clinical Blocking of PD-L1 Molecule, Which Expression Is down Regulated by NF-κB, JAK1/JAK2 and BTK Inhibitors, Induces Regression of Activated B-Cell Lymphoma. Cell Communication and Signal-ing, 17, 89. [Google Scholar] [CrossRef] [PubMed]
[45] 任亚琳. B7-CD28家族成员的免疫调节功能及其最新研究进展[J]. 国外医学(免疫学分册), 2005, 28(6): 324-328.
[46] Parry, R.V., Chemnitz, J.M., Frauwirth, K.A., et al. (2005) CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms. Molecular and Cellular Biology, 25, 9543-9553. [Google Scholar] [CrossRef] 
[47] Deng, J., Qian, Y., Geng, L., et al. (2011) Involvement of ERK and JNK Pathways in IFN-γ-Induced B7-DC Expression on Tumor Cells. Journal of Cancer Research and Clinical Oncology, 137, 243-250. [Google Scholar] [CrossRef] [PubMed]
[48] Tseng, S.Y., Otsuji, M., Gorski, K., et al. (2001) B7-DC, a New Dendritic Cell Molecule with Potent Costimulatory Properties for T Cells. Journal of Experimental Medicine, 193, 839-846. [Google Scholar] [CrossRef] [PubMed]
[49] Li, Q.L., Wu, Y.Y., Sun, H.M., et al. (2019) The Role of miR-29c/B7-H3/Th17 Axis in Children with Mycoplasma pneumoniae Pneumonia. Italian Journal of Pediatrics, 45, 61. [Google Scholar] [CrossRef] [PubMed]
[50] 周楠楠, 廖海秀, 杨英, 丁萌, 唐伟, 陈礼文. B7-H3上调IL-22表达在肺腺癌中的临床意义[J]. 安徽医科大学学报, 2021, 56(11): 1793-1797.
[51] 吴爱萍, 朱斌. 支原体肺炎患儿血清sB7-H3、IFN-γ、GM-CSF的变化观察[J]. 临床肺科杂志, 2019, 24(6): 1042-1045.
[52] Zhang, G., Wang, J., Kelly, J., et al. (2010) B7-H3 Augments the Inflammatory Response and Is Associated with Human Sepsis. The Journal of Immunology, 185, 3677-3684. [Google Scholar] [CrossRef] [PubMed]
[53] Li, G., Fan, L., Wang, Y., et al. (2019) High Co-Expression of TNF-α and CARDS Toxin Is a Good Predictor for Refractory Myco-plasma pneumoniae Pneumonia. Molecular Medicine, 25, 38. [Google Scholar] [CrossRef] [PubMed]
[54] 姜之焕, 武怡. 儿童MPP肺泡灌洗液中sB7-H3、IFN-γ的表达水平及临床意义[J]. 徐州医科大学学报, 2020, 40(2): 114-117.
[55] Choi, I.H., Zhu, G., Sica, G.L., et al. (2003) Genomic Organization and Expression Analysis of B7-H4, an Immune Inhibitory Molecule of the B7 Family. The Journal of Immunology, 171, 4650-4654. [Google Scholar] [CrossRef] [PubMed]
[56] Podojil, J.R., Liu, L.N., Marshall, S.A., et al. (2013) B7-H4Ig Inhibits Mouse and Human T-Cell Function and Treats EAE via IL-10/Treg-Dependent Mechanisms. Journal of Auto-immunity, 44, 71-81. [Google Scholar] [CrossRef] [PubMed]
[57] 肖欢, 潘卫民, 王超群, 陈鸿颜, 徐军发. B7-H4对ConA诱导小鼠肝损伤保护作用的实验研究[J]. 四川大学学报(医学版), 2015, 46(6): 842-845.
[58] 郭杰. 猪B7-H4的基因克隆、单抗制备及其在猪肺炎支原体感染肺脏组织中的表达分析[D]: [硕士学位论文]. 北京: 中国农业科学院, 2018.

为你推荐